Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical ...

Two of the scientists who work at the U.S. Food and Drug Administration said they had been assigned around double the number ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

From new partnerships to product launches, here are 12 key developments in orthobiologics during the first quarter of 2025. 1. Medtronic and Kuros Biosciences signed a strategic agreement to support ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

The evolution of the safety and effectiveness evaluation of endovascular grafts intended for abdominal aortic aneurysm repair ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

The people involved in the study have rare genetic mutations, making it nearly certain they will develop Alzheimer's. AP reports on how mass firings and funding restrictions at the NIH are affecting ...

The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.